Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tonge

Showing results (761-770 of 775) with videos related to

Pageof 78
Sort By:
Cancer Research|March 30, 2016
AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and ESR1-Mutant Breast Tumors in Preclinical ModelsHazel M Weir, Robert H Bradbury, Mandy Lawson, et al.
Journal of Medicinal Chemistry|September 26, 2015
Optimization of a Novel Binding Motif to (E)-3-(3,5-Difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl)acrylic Acid (AZD9496), a Potent and Orally Bioavailable Selective Estrogen Receptor Downregulator and AntagonistChris De Savi, Robert H Bradbury, Alfred A Rabow, et al.
Cancer Letters|March 14, 2026
Identification of the MRTFA/SRF pathway as a critical regulator of quiescence and chemotherapy resistance in cancerSantiago Panesso-Gómez, Alexander J Cole, Austin Arrigo, et al.
Australian and New Zealand Journal of Public Health|April 18, 2022
A review of Australian Government funding of parenting intervention researchSophie S Havighurst, Carys Chainey, Frances L Doyle, et al.
Journal of Medicinal Chemistry|November 12, 2019
Discovery of a Potent and Selective Oral Inhibitor of ERK1/2 (AZD0364) That Is Efficacious in Both Monotherapy and Combination Therapy in Models of Nonsmall Cell Lung Cancer (NSCLC)Richard A Ward, Mark J Anderton, Paul Bethel, et al.
Science Advances|October 15, 2025
Impact of intermittent lead exposure on hominid brain evolutionRenaud Joannes-Boyau, Janaina Sena de Souza, Manish Arora, et al.
Thorax|November 14, 2018
Second round results from the Manchester 'Lung Health Check' community-based targeted lung cancer screening pilotPhil A Crosbie, Haval Balata, Matthew Evison, et al.
Nature|December 16, 2014
Genome-wide characterization of the routes to pluripotencySamer M I Hussein, Mira C Puri, Peter D Tonge, et al.
Nature Communications|August 7, 2024
Male autism spectrum disorder is linked to brain aromatase disruption by prenatal BPA in multimodal investigations and 10HDA ameliorates the related mouse phenotypeChristos Symeonides, Kristina Vacy, Sarah Thomson, et al.
Journal of Medicinal Chemistry|February 6, 2020
Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRAS<sup>G12C</sup>Jason G Kettle, Sharan K Bagal, Sue Bickerton, et al.
Pageof 78

Showing results (761-770 of 775) with videos related to

Sort By:
Pageof 78
Cancer Research|March 30, 2016
AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and ESR1-Mutant Breast Tumors in Preclinical ModelsHazel M Weir, Robert H Bradbury, Mandy Lawson, et al.
Journal of Medicinal Chemistry|September 26, 2015
Optimization of a Novel Binding Motif to (E)-3-(3,5-Difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl)acrylic Acid (AZD9496), a Potent and Orally Bioavailable Selective Estrogen Receptor Downregulator and AntagonistChris De Savi, Robert H Bradbury, Alfred A Rabow, et al.
Cancer Letters|March 14, 2026
Identification of the MRTFA/SRF pathway as a critical regulator of quiescence and chemotherapy resistance in cancerSantiago Panesso-Gómez, Alexander J Cole, Austin Arrigo, et al.
Australian and New Zealand Journal of Public Health|April 18, 2022
A review of Australian Government funding of parenting intervention researchSophie S Havighurst, Carys Chainey, Frances L Doyle, et al.
Journal of Medicinal Chemistry|November 12, 2019
Discovery of a Potent and Selective Oral Inhibitor of ERK1/2 (AZD0364) That Is Efficacious in Both Monotherapy and Combination Therapy in Models of Nonsmall Cell Lung Cancer (NSCLC)Richard A Ward, Mark J Anderton, Paul Bethel, et al.
Science Advances|October 15, 2025
Impact of intermittent lead exposure on hominid brain evolutionRenaud Joannes-Boyau, Janaina Sena de Souza, Manish Arora, et al.
Thorax|November 14, 2018
Second round results from the Manchester 'Lung Health Check' community-based targeted lung cancer screening pilotPhil A Crosbie, Haval Balata, Matthew Evison, et al.
Nature|December 16, 2014
Genome-wide characterization of the routes to pluripotencySamer M I Hussein, Mira C Puri, Peter D Tonge, et al.
Nature Communications|August 7, 2024
Male autism spectrum disorder is linked to brain aromatase disruption by prenatal BPA in multimodal investigations and 10HDA ameliorates the related mouse phenotypeChristos Symeonides, Kristina Vacy, Sarah Thomson, et al.
Journal of Medicinal Chemistry|February 6, 2020
Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRAS<sup>G12C</sup>Jason G Kettle, Sharan K Bagal, Sue Bickerton, et al.
Pageof 78